Home » Newsletters » BioWorld

BioWorld

Feb. 7, 2000

View Archived Issues

NeoRx Moves Skeletal Targeted Radiotherapy To Phase III Study

Genzyme Transgenics Raises $70M In Public Stock Offering

Other News To Note

Agouron, PPD In $30M Pact To Find Targets Against HIV

Lab Rats Treated With Switched Amino Acid Peptide Overcame Prostate Cancer Lung Metastasis

Biotech Could Be Affected By FASB Interest-Pooling Hearings

COR's Integrilin Succeeds In Coronary Intervention Study

Rigel Continues Run Of Filings As It Seeks $100M Through IPO

Antigenics' IPO Raises $63M To Fund Trials Of Oncophage